These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 8996210)

  • 1. Adenosine A2 receptor activation attenuates reperfusion injury by inhibiting neutrophil accumulation, superoxide generation and coronary endothelial adherence.
    Jordan JE; Zhao ZQ; Sato H; Taft S; Vinten-Johansen J
    J Pharmacol Exp Ther; 1997 Jan; 280(1):301-9. PubMed ID: 8996210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood cardioplegia supplementation with the sodium-hydrogen ion exchange inhibitor cariporide to attenuate infarct size and coronary artery endothelial dysfunction after severe regional ischemia in a canine model.
    Muraki S; Morris CD; Budde JM; Zhao ZQ; Guyton RA; Vinten-Johansen J
    J Thorac Cardiovasc Surg; 2003 Jan; 125(1):155-64. PubMed ID: 12538999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant human complement C5a receptor antagonist reduces infarct size after surgical revascularization.
    Riley RD; Sato H; Zhao ZQ; Thourani VH; Jordan JE; Fernandez AX; Ma XL; Hite DR; Rigel DF; Pellas TC; Peppard J; Bill KA; Lappe RW; Vinten-Johansen J
    J Thorac Cardiovasc Surg; 2000 Aug; 120(2):350-8. PubMed ID: 10917953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet-activating factor antagonism attenuates platelet and neutrophil activation and reduces myocardial injury during coronary reperfusion.
    Ko W; Lang D; Hawes AS; Zelano JA; Isom OW; Krieger KH
    J Surg Res; 1993 Nov; 55(5):504-15. PubMed ID: 8231170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenosine inhibition of neutrophil damage during reperfusion does not involve K(ATP)-channel activation.
    Zhao ZQ; Todd JC; Sato H; Ma XL; Vinten-Johansen J
    Am J Physiol; 1997 Oct; 273(4):H1677-87. PubMed ID: 9362230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenosine A2-receptor activation inhibits neutrophil-mediated injury to coronary endothelium.
    Zhao ZQ; Sato H; Williams MW; Fernandez AZ; Vinten-Johansen J
    Am J Physiol; 1996 Oct; 271(4 Pt 2):H1456-64. PubMed ID: 8897940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental off-pump coronary artery revascularization with adenosine-enhanced reperfusion.
    Muraki S; Morris CD; Budde JM; Velez DA; Zhao ZQ; Guyton RA; Vinten-Johansen J
    J Thorac Cardiovasc Surg; 2001 Mar; 121(3):570-9. PubMed ID: 11241093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenosine attenuates reperfusion-induced apoptotic cell death by modulating expression of Bcl-2 and Bax proteins.
    Zhao ZQ; Budde JM; Morris C; Wang NP; Velez DA; Muraki S; Guyton RA; Vinten-Johansen J
    J Mol Cell Cardiol; 2001 Jan; 33(1):57-68. PubMed ID: 11133223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. L-Arginine inhibits neutrophil adherence and coronary artery dysfunction.
    Sato H; Zhao ZQ; Vinten-Johansen J
    Cardiovasc Res; 1996 Jan; 31(1):63-72. PubMed ID: 8849590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of the cardioprotective actions of WEB-2170, bepafant, a platelet activating factor antagonist, in myocardial ischemia and reperfusion.
    Ma XL; Weyrich AS; Krantz S; Lefer AM
    J Pharmacol Exp Ther; 1992 Mar; 260(3):1229-36. PubMed ID: 1545390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardioprotection by liposome-conjugated sialyl Lewisx-oligosaccharide in myocardial ischaemia and reperfusion injury.
    Murohara T; Margiotta J; Phillips LM; Paulson JC; DeFrees S; Zalipsky S; Guo LS; Lefer AM
    Cardiovasc Res; 1995 Dec; 30(6):965-74. PubMed ID: 8746213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardioprotective effects of the novel adenosine A1/A2 receptor agonist AMP 579 in a porcine model of myocardial infarction.
    Smits GJ; McVey M; Cox BF; Perrone MH; Clark KL
    J Pharmacol Exp Ther; 1998 Aug; 286(2):611-8. PubMed ID: 9694911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term inhibition of myocardial infarction by postconditioning during reperfusion.
    Mykytenko J; Kerendi F; Reeves JG; Kin H; Zatta AJ; Jiang R; Guyton RA; Vinten-Johansen J; Zhao ZQ
    Basic Res Cardiol; 2007 Jan; 102(1):90-100. PubMed ID: 17003965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haemodynamic effects of a selective adenosine A2A receptor agonist, CGS 21680, in chronic heart failure in anaesthetized rats.
    Nekooeian AA; Tabrizchi R
    Br J Pharmacol; 1998 Oct; 125(4):651-8. PubMed ID: 9831898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic progression of contractile and endothelial dysfunction and infarct extension in the late phase of reperfusion.
    Zhao ZQ; Nakamura M; Wang NP; Velez DA; Hewan-Lowe KO; Guyton RA; Vinten-Johansen J
    J Surg Res; 2000 Dec; 94(2):133-44. PubMed ID: 11104653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A(3) adenosine receptor activation attenuates neutrophil function and neutrophil-mediated reperfusion injury.
    Jordan JE; Thourani VH; Auchampach JA; Robinson JA; Wang NP; Vinten-Johansen J
    Am J Physiol; 1999 Nov; 277(5):H1895-905. PubMed ID: 10564145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelial and myocardial cell protection by a cysteine-containing nitric oxide donor after myocardial ischemia and reperfusion.
    Lefer DJ; Nakanishi K; Vinten-Johansen J
    J Cardiovasc Pharmacol; 1993; 22 Suppl 7():S34-43. PubMed ID: 7504767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phorbol ester-stimulated adherence of neutrophils to endothelial cells is reduced by adenosine A2 receptor agonists.
    Felsch A; Stöcker K; Borchard U
    J Immunol; 1995 Jul; 155(1):333-8. PubMed ID: 7602109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of nicorandil and glyceryl trinitrate on infarct size, adenosine release, and neutrophil infiltration in the dog.
    Mizumura T; Nithipatikom K; Gross GJ
    Cardiovasc Res; 1995 Apr; 29(4):482-9. PubMed ID: 7796441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of experimental canine myocardial infarct size with prostaglandin E1: inhibition of neutrophil migration and activation.
    Simpson PJ; Mickelson J; Fantone JC; Gallagher KP; Lucchesi BR
    J Pharmacol Exp Ther; 1988 Feb; 244(2):619-24. PubMed ID: 2831348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.